TCL Archive In Brief: Carbone To Leave NCI for Wisconsin ACS’ Holleb Says Tobacco Industry Tries to Hide Ad Warning October 3, 1975
TCL Archive Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease December 28, 2012
TCL Archive Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development. January 13, 2006